Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

PRN Member Menu

Due to the COVID-19 pandemic, all meetings are now via the Zoom Webinar platform.
Pre-Register Here
Please help PRN by taking the pre-meeting evaluation. These surveys are critical to the future of our programs and accreditation.
Pre-Meeting Survey
MEETING AND CME INFORMATION

PRN Meeting: May 18, 2022 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Course Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

HIV Remission in a Woman of Mixed Race with AML and HIV: The New York Patient

Marshall Glesby, MD, PhD

Associate Chief, Division of Infectious Diseases
Director, Cornell HIV Clinical Trials Unit
Weill Cornell Medical College, New York, NY

- and -

Deborah Persaud, MD
Professor, Department of Pediatrics
Interim Chief, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Dept. of Molecular Microbiology and Immunology and International Health
Johns Hopkins Bloomberg School of Public Health
Chair, IMPAACT HIV Cure Scientific Committee, Baltimore, MD

Learning Objectives:

At the completion of this educational session, participants will:
1. Describe the barriers to HIV cure.
2. Recognize why HIV remission and cure occurred through stem cell transplantation.
3. Discuss the relevance of different assays used to measure HIV persistence and its limitations in HIV cure research.

Weight Gain and Obesity in People with HIV

Todd T. Brown, MD, PhD

Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes, and Metabolism
Johns Hopkins University, Baltimore, MD

Learning Objectives:

At the completion of this educational session, participants will:
1. Review the current evidence regarding the impact of ART and specific ART medications on body weight.
2. Understand the impact of weight gain and adipose distribution on clinical outcomes.
3. Know the optimal approaches to weight gain prevention and treatment in PWH.
4. Be aware of new treatments that are being developed for weight loss.

Accreditation Statement: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. Dr. Braun (Planner/Course Director/ Moderator) has no relevant financial relationships to disclose.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

PRN Member Menu

Are you a member? If so, please log-in.

Not a member? Please register.

Have you forgotten your password?